Essential (primary) hypertension
Conditions
Interventions
This is a three-arm, single-blind, randomized controlled clinical trial. Experimental group 1: 26 medicated hypertensive elderly women will receive remote training with calisthenics exercises to be pe
Sponsors
Universidade Federal de Uberlândia
Universidade Federal de Uberlândia
Eligibility
Sex/Gender
Female
Age
60 Years to 75 Years
Inclusion criteria
Inclusion criteria: Women aged between 60 and 75 years; vaccinated against COVID-19; duly medicated hypertensive patients; non smokers; with a BMI below 32 kg/m²; non-practitioners of physical exercise on a regular and systematic basis for at least three months; without musculoskeletal problems or cardiovascular complications (besides hypertension) that prevent the practice of systematic physical exercises; no diagnosis of Type I Diabetes Mellitus or lung disease; with medical evaluation involving a clinical anamnesis and medical certificate releasing the participation in a training program with physical exercises
Exclusion criteria
Exclusion criteria: Mulheres não vacinadas contra COVID-19; hipertensas não-medicadas; fumantes; com IMC acima de 32 kg/m²; praticantes de exercícios físicos de forma regular e sistemática; com problemas osteomusculares ou complicações cardiovasculares impedindo a prática de exercícios físicos sistemáticos; com diagnóstico de Diabetes Mellitus tipo I ou doença pulmonar; sem avaliação médica envolvendo uma anamnese clínica e atestado médico liberando a participação em um programa de treinamento com exercícios físicos
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A decrease in systolic and diastolic blood pressure (<140/90 mmHg) or maintenance of normal values (up to 120/80 mmHg) is expected, verified through clinical and outpatient measurements, in the post-intervention period. | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to verify the decrease in blood pressure reactivity through physical and mental stress tests; to increase the heart rate variability of volunteers who do not use beta-blockers, evaluated using heart rate monitors; improve sleep quality, as measured using the Pittsburg Sleep Quality Index; improve body composition, reducing fat mass and increasing lean mass, measured through bioimpedance; increase functional skills, assessed through functional tests specific to the elderly population; reduce to ideal levels the values of total cholesterol, fractions and triglycerides, in addition to glycemia, measured through laboratory blood tests; reduce concentrations of pro-inflammatory cytokines, measured through laboratory tests of blood and saliva after interventions | — |
Countries
Brazil
Contacts
Public ContactTállita Cristina Souza
Faculdade de Medicina - UFU
Outcome results
None listed